RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 24 - per page Next page
Order by
ReGen Therapeutics Plc ('ReGen' or 'the Company') is developing an important new use for zolpidem, a long-established and safe treatment for insomnia. More
Sosei today announces that it has entered into an agreement with Mundipharma International for the development and commercialisation of AD 923, Sosei's novel sublingual fentanyl spray for cancer breakthrough pain, in Europe and other markets. More
New edition of report on opportunities in Indian pharma and biotech features partnering opportunities in companies, life science research institutes and biotech parks More
With deals increasing in terms of number and value, partnering at early stage development is now an integral component of pharmaceutical and biotech business strategy. Pharmalicensing has revised and updated its successful Early Stage report More
Pharmalicensing launches revised versions of its Deals Briefings with up-to-date data More
New edition of report on opportunities in Indian pharma and biotech features partnering opportunities in companies, life science research institutes and biotech parks More
Partneringdesk Deals and Alliances therapy reports are revised with up-to-date deals More
Pharmalicensing launches revised versions of its Deals Briefings with up-to-date data More
New edition of Partneringreview summarizes pharma and biotech deals of 2005 More
Innocoll, Inc. announced its sales and marketing subsidiary, Innocoll Pharmaceuticals Ltd., has launched a new version of its CollaRx Gentamicin Surgical Implant that is specially designed for maximum convenience and ease of use in cardiac surgery. More
Displaying 1..10 of 24 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us